168 related articles for article (PubMed ID: 36241426)
1. Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.
Sconocchia G; Lanzilli G; Cesarini V; Silvestris DA; Rezvani K; Arriga R; Caratelli S; Chen K; Dou J; Cenciarelli C; Toietta G; Baldari S; Sconocchia T; De Paolis F; Aureli A; Iezzi G; Irno Consalvo M; Buccisano F; Del Principe MI; Maurillo L; Venditti A; Ottaviani A; Spagnoli GC
Life Sci Alliance; 2022 Dec; 5(12):. PubMed ID: 36241426
[TBL] [Abstract][Full Text] [Related]
2. In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.
Caratelli S; Arriga R; Sconocchia T; Ottaviani A; Lanzilli G; Pastore D; Cenciarelli C; Venditti A; Del Principe MI; Lauro D; Landoni E; Du H; Savoldo B; Ferrone S; Dotti G; Sconocchia G
Int J Cancer; 2020 Jan; 146(1):236-247. PubMed ID: 31479522
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy.
Luangwattananun P; Junking M; Sujjitjoon J; Wutti-In Y; Poungvarin N; Thuwajit C; Yenchitsomanus PT
Breast Cancer Res Treat; 2021 Feb; 186(1):25-36. PubMed ID: 33389403
[TBL] [Abstract][Full Text] [Related]
4. Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.
Alabanza L; Pegues M; Geldres C; Shi V; Wiltzius JJW; Sievers SA; Yang S; Kochenderfer JN
Mol Ther; 2017 Nov; 25(11):2452-2465. PubMed ID: 28807568
[TBL] [Abstract][Full Text] [Related]
5. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
[TBL] [Abstract][Full Text] [Related]
6. Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils.
Kim JT; Schimming AW; Kita H
J Immunol; 1999 Apr; 162(7):4253-9. PubMed ID: 10201955
[TBL] [Abstract][Full Text] [Related]
7. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
[TBL] [Abstract][Full Text] [Related]
8. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
9. Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation.
Friedmann-Morvinski D; Bendavid A; Waks T; Schindler D; Eshhar Z
Blood; 2005 Apr; 105(8):3087-93. PubMed ID: 15626734
[TBL] [Abstract][Full Text] [Related]
10. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
11. Genetically targeted T cells eradicate established breast cancer in syngeneic mice.
Wang H; Wei H; Zhang R; Hou S; Li B; Qian W; Zhang D; Kou G; Dai J; Guo Y
Clin Cancer Res; 2009 Feb; 15(3):943-50. PubMed ID: 19188165
[TBL] [Abstract][Full Text] [Related]
12. CD32 Ligation Promotes the Activation of CD4
Holgado MP; Sananez I; Raiden S; Geffner JR; Arruvito L
Front Immunol; 2018; 9():2814. PubMed ID: 30555482
[TBL] [Abstract][Full Text] [Related]
13. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Badia R; Ballana E; Castellví M; García-Vidal E; Pujantell M; Clotet B; Prado JG; Puig J; Martínez MA; Riveira-Muñoz E; Esté JA
Nat Commun; 2018 Jul; 9(1):2739. PubMed ID: 30013105
[TBL] [Abstract][Full Text] [Related]
14.
Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
[TBL] [Abstract][Full Text] [Related]
15. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2
Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE
Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641
[No Abstract] [Full Text] [Related]
16. Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor.
Zuo BL; Yan B; Zheng GX; Xi WJ; Zhang X; Yang AG; Jia LT
Cancer Immunol Immunother; 2018 Mar; 67(3):393-401. PubMed ID: 29127433
[TBL] [Abstract][Full Text] [Related]
17. Construction and evaluation of a novel humanized HER2-specific chimeric receptor.
Sun M; Shi H; Liu C; Liu J; Liu X; Sun Y
Breast Cancer Res; 2014 Jun; 16(3):R61. PubMed ID: 24919843
[TBL] [Abstract][Full Text] [Related]
18. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo.
Song DG; Ye Q; Poussin M; Harms GM; Figini M; Powell DJ
Blood; 2012 Jan; 119(3):696-706. PubMed ID: 22117050
[TBL] [Abstract][Full Text] [Related]
19. A regulatory role for Fcgamma receptors CD16 and CD32 in the development of murine B cells.
de Andres B; Mueller AL; Verbeek S; Sandor M; Lynch RG
Blood; 1998 Oct; 92(8):2823-9. PubMed ID: 9763567
[TBL] [Abstract][Full Text] [Related]
20. Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function.
Nguyen P; Moisini I; Geiger TL
Blood; 2003 Dec; 102(13):4320-5. PubMed ID: 12946999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]